tbuckley/cabot-search huggingface dataset:
Daratumumab plus Bortezomib, Melphalan, and Prednisone for Untreated Myeloma
Authors: María-Victoria Mateos, Meletios A. Dimopoulos, Michele Cavo, Kenshi Suzuki, Andrzej Jakubowiak, Stefan Knop, Chantal Doyen, Paulo Lucio, Zsolt Nagy, Polina Kaplan, Ludek Pour, Mark Cook, Sebastian Grosicki, Andre Crepaldi, Anna M. Liberati, Philip Campbell, Tatiana Shelekhova, Sung-Soo Yoon, Genadi Iosava, Tomoaki Fujisaki, Mamta Garg, Christopher Chiu, Jianping Wang, Robin Carson, Wendy Crist, William Deraedt, Huong Nguyen, Ming Qi, Jesus San-Miguel
Journal: New England Journal of Medicine (2017)

The combination of bortezomib, melphalan, and prednisone is a standard treatment for patients with newly diagnosed multiple myeloma who are ineligible for autologous stem-cell transplantation. Daratumumab has shown efficacy in combination with standard-of-care regimens in patients with relapsed or refractory multiple myeloma.
A segurança dos bancos de sangue e o teste de ácidos nucleicos (NAT) na Europa
Authors: S Laperche
Journal: Eurosurveillance (2005)

Uma larga serie de medidas, especificas ou nao, foram introduzidas nas duas ultimas decadas, no rastreio das doacoes sanguineas para reduzir o risco residual de transmissao de infeccoes virais. O teste dos acidos nucleicos (NAT, nucleic acid testing) e a ultima medida especifica introduzida em 1995 pela industria do plasma e posteriormente utilizada nas doacoes de sangue em varios paises da Europa e fora da Europa. O NAT foi implementado para responder a necessidade de reforcar a seguranca dos bancos de sangue porque este teste permite de detectar durante o periodo da “janela serologica”, as infeccoes virais agudas que nao foram detectadas pelos metodos de rastreio convencionais. As estimacoes dos riscos residuais de infeccoes virais transmitidas pelo sangue sao essenciais para avaliar o impacto deste novo teste de rastreio na seguranca dos bancos de sangue. Nesta edicao, seis paises Europeus (Franca, Alemanha, Italia, Espanha, Suica e Reino Unido), nos quais o NAT foi implementado recentemente, descrevem a sua experiencia e o resultado da evaliacao dos riscos residuais de infeccoes virais nos seus componentes de sangue [1-6].
Role of up-front autologous stem-cell transplantation in peripheral T-cell lymphoma for patients in response after induction: an analysis of patients from LYSA centers
Authors: G. Fossard, F. Broussais, I. Coelho, S. Bailly, E. Nicolas-Virelizier, E. Toussaint, C. Lancesseur, F. Le Bras, E. Willems, E. Tchernonog, T. Chalopin, R. Delarue, R. Gressin, A. Chauchet, E. Gyan, G. Cartron, C. Bonnet, C. Haioun, G. Damaj, P. Gaulard, L. Fornecker, H. Ghesquières, O. Tournilhac, M. Gomes da Silva, R. Bouabdallah, G. Salles, E. Bachy
Journal: Annals of Oncology (2017)
Zoledronic Acid Dosing in Patients With Metastatic Breast Cancer
Authors: Takahiro Hasegawa, Hajime Uno, Lee-Jen Wei
Journal: JAMA Oncology (2017)

Our website uses cookies to enhance your experience. By continuing to use our site, or clicking "Continue," you are agreeing to our Cookie Policy | Continue JAMA Oncology HomeNew OnlineCurrent IssueFor Authors Podcast Publications JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry (1919-1959) JN Learning / CMESubscribeJobsInstitutions / LibrariansReprints & Permissions Terms of Use | Privacy Policy | Accessibility Statement 2023 American Medical Association. All Rights Reserved Search All JAMA JAMA Network Open JAMA Cardiology JAMA Dermatology JAMA Forum Archive JAMA Health Forum JAMA Internal Medicine JAMA Neurology JAMA Oncology JAMA Ophthalmology JAMA Otolaryngology–Head & Neck Surgery JAMA Pediatrics JAMA Psychiatry JAMA Surgery Archives of Neurology & Psychiatry Input Search Term Sign In Individual Sign In Sign inCreate an Account Access through your institution Sign In Purchase Options: Buy this article Rent this article Subscribe to the JAMA Oncology journal
Investigación de un brote de infecciones por E. coli O157 asociadas a un viaje a Francia realizado por alumnos de un instituto de Somerset, Inglaterra
Authors: E Duffell, E Espié, T Nichols, G K Adak, H de Valk, J M Stuart
Journal: Eurosurveillance (2003)

Tras la aparicion de dos casos confirmados y ocho probables de VTEC 0157 en un grupo de alumnos de un instituto de Somerset despues de regresar de un viaje a Francia, se realizo un estudio de cohorte retrospectivo. En los dos casos confirmados se detecto vero-citotoxina tipo 2, fagotipo 34. Pese a su baja potencia estadistica debida al numero reducido de casos, este estudio sugiere que el vehiculo de infeccion mas probable fue la ensalada de pepino (RR crudo =4,3, IC 95% [0,6-29], OR ajustado =107, IC 95% indeterminado, p=0,08). Los pepinos se adquirieron en Belgica pero no fue posible comprobar su origen. La indole internacional de este brote pone de manifiesto la importancia de que exista una estrecha colaboracion entre organizaciones en el manejo de brotes, de que se garanticen estandares internacionales en materia de seguridad alimentaria y de que se acuerde un estandar comun a toda Europa para la tipificacion de VTEC.
Alveolar T-helper 17 responses to streptococcus pneumoniae are preserved in ART-untreated and treated HIV-infected Malawian adults
Authors: Chikondi Peno, Dominic H. Banda, Ndaru Jambo, Anstead M. Kankwatira, Rose D. Malamba, Theresa J. Allain, Daniela M. Ferreira, Robert S. Heyderman, David G. Russell, Henry C. Mwandumba, Kondwani C. Jambo
Journal: Journal of Infection (2017)

Highlights•Pneumococcal-specific Th17 responses in HIV-infected adults are preserved.•The frequency of pneumococcal-specific Th17 cells is increased in ART-treated HIV-infected adults.•Depletion of pneumococcal-specific Th17 cells is unlikely the reason behind the increased susceptibility to pneumonia in HIV-infected adults.SummaryObjectiveWe explored if HIV infection is associated with impaired T-Helper 17 responses against Streptococcus pneumoniae in the lung.MethodsWe recruited 30 HIV-uninfected healthy controls, 23 asymptomatic HIV-infected adults not on ART, and 40 asymptomatic HIV-infected adults on ART (Median time 3.5yrs), in whom we collected bronchoalveolar lavage fluid. We measured alveolar CD4+ T cell immune responses following stimulation with pneumococcal cell culture supernatant using flow cytometry-based intracellular cytokine staining.ResultsWe found that the proportion of alveolar CD4+ T cells producing IL-17A following stimulation with pneumococcal cell culture supernatant (CCS) was similar between HIV-uninfected controls and ART-naïve HIV-infected adults (0.10% vs. 0.14%; p = 0.9273). In contrast, the proportion and relative absolute counts of CD4+ T cells producing IL-17A in response to pneumococcal CCS were higher in ART-treated HIV-infected adults compared HIV-uninfected controls (0.22% vs. 0.10%, p = 0.0166; 5420 vs. 1902 cells/100 ml BAL fluid; p = 0.0519). The increase in relative absolute numbers of IL-17A-producing alveolar CD4+ T cells in ART-treated individuals was not correlated with the peripheral blood CD4+ T cell count (r=–0.1876, p = 0.1785).ConclusionAlveolar Th17 responses against S. pneumoniae are preserved in HIV-infected adults. This suggests that there are other alternative mechanisms that are altered in HIV-infected individuals that render them more susceptible to pneumococcal pneumonia.
Abstract IA08: Personalizing HNSCC treatment based on TP53 mutational status
Authors: Jeffrey Myers
Journal: Clinical Cancer Research (2017)

Abstract Head and neck squamous cell carcinoma (HNSCC) is a leading cause of cancer deaths worldwide, and resistance to standard treatments with radiation/chemotherapy accounts for the majority of HNSCC deaths. Mutation of TP53 occurs in 60-85% of non-HPV-associated HNSCC cases, and some mutant p53s display oncogenic properties, termed “gain-of-function (GOF),” which are independent of wild-type (WT) p53 functions. These GOF p53 mutant proteins can enhance cell transformation, increase tumor formation, and confer cellular resistance to chemo- and/or radio-therapy. Therefore, we are interested in the development of innovative therapeutic approaches to overcome this resistance. Pre-clinical studies both in vitro and in vivo have shown the promise of some novel targeted agents including Chk-1, Wee-1, and PARP inhibitors used alone or in combination with HDAC inhibition. In addition, COTI-2 is a novel drug with striking single-agent and radio-/chemo-sensitizing activity in pre-clinical models of HNSCC bearing TP53 mutations. Our preliminary data demonstrate that COTI-2 markedly decreases cell growth in vitro and induces p21, noxa, and puma expression in HNSCC cells. COTI-2 also negatively modulates the PI3K/AKT/mTOR survival pathway, which is constitutively activated in many types of cancer including HNSCC. In vitro studies in our laboratory have shown that COTI-2 has a nanomolar (IC50: 1.3-13.2 nm) activity in nine human HNSCC cell lines. Additionally, GOF mutant p53-bearing HNSCC cells are significantly delayed in outgrowth in an orthotopic nude mouse model of tongue cancer when treated with COTI-2. Current clinical studies are evaluating the safety and efficacy of the combination of COTI-2 alone and in combination with cisplatin in phase I/II studies of patients with refractory HNSCC and whether response is associated with TP53 mutational status of the tumor determined from sequencing of circulating cell free DNA. If this combination is found to safely provide sensitization of HNSCC to cisplatin-based chemotherapy in the majority of human patients who have TP 53 mutant tumors, this should make a major impact on the survival of individuals suffering from HNSCC, and potentially other p53 driven epithelial malignancies. Citation Format: Jeffrey Myers. Personalizing HNSCC treatment based on TP53 mutational status [abstract]. In: Proceedings of the AACR-AHNS Head and Neck Cancer Conference: Optimizing Survival and Quality of Life through Basic, Clinical, and Translational Research; April 23-25, 2017; San Diego, CA. Philadelphia (PA): AACR; Clin Cancer Res 2017;23(23_Suppl):Abstract nr IA08.
Prophylactic Use of a Combination of an Anticoagulant and Ursodeoxycholic Acid for Sinusoidal Obstruction Syndrome after Allogeneic Myeloablative Hematopoietic Stem Cell Transplantation
Authors: Hiroshi Okamura, Mitsutaka Nishimoto, Takahiko Nakane, Hideo Koh, Yasuhiro Nakashima, Yasunobu Takeoka, Mika Nakamae, Asao Hirose, Masayuki Hino, Hirohisa Nakamae
Journal: Blood (2016)
Updated European Association of Urology Guidelines: Recommendations for the Treatment of First-line Metastatic Clear Cell Renal Cancer
Authors: Thomas Powles, Laurence Albiges, Michael Staehler, Karim Bensalah, Saeed Dabestani, Rachel H. Giles, Fabian Hofmann, Milan Hora, Markus A. Kuczyk, Thomas B. Lam, Lorenzo Marconi, Axel S. Merseburger, Sergio Fernández-Pello, Rana Tahbaz, Alessandro Volpe, Börje Ljungberg, Axel Bex
Journal: European Urology (2017)
Abstract 15174: Failing Aortic Tissue Valves in Patients at High Surgical Risk: Comparison of Outcomes After Transcatheter Aortic Valve-in-valve Procedures and Redo Surgical Aortic Valve Replacement
Authors: Miriam Silaschi, Olaf Wendler, Liesa Castro, Moritz Seiffert, Edith Lubos, Stefan Blankenberg, Hermann Reichenspurner, Ulrich Schäfer, Hendrik Treede, Philip MacCarthy, Lenard Conradi
Journal: Circulation (2015)

Objectives: Transcatheter aortic valve-in-valve implantation (ViV) is an innovative treatment for failed tissue valves (TV) in patients at high surgical risk. However, direct comparative data with standard repeat surgical aortic valve replacement (RE-SAVR) is scarce. We aimed to compare outcomes after ViV to conventional RE-SAVR in two European centers with established interventional programs. Methods: Retrospectively we explored in-hospital databases for patients ≥60 years, treated for degenerated TV. Patients with endocarditis and combined procedures were excluded. Primary endpoints were adjudicated according to VARC-2 criteria. Results: Between 2002 and 2015, 130 patients were treated for isolated failure of aortic TV’s (ViV: n=71, RE-SAVR: n=59). In ViV, Edwards Sapien valve (ESV) was most frequently used (n=36) but implanted into larger TV’s (CoreValve TV size: 22.2±1.3mm vs. ESV TV size: 24.1±2.0mm, p&lt;0.01). Both age and logistic EuroSCORE I were higher in ViV compared to RE-SAVR (78.6±7.5 vs. 72.9±6.5 ys, p&lt;0.01; 25.1±18.9 vs. 16.8±9.4%, p&lt;0.01). Thirty-day mortality was not significantly different with 4.2% (3/71) after ViV vs. 5.1% (3/59) post RE-SAVR (p=1.0). Device success was achieved in 54.9% (n=39) in ViV and all RE-SAVR patients (p&lt;0.01). Perioperative stroke was not observed after ViV and in 2 patients after RE-SAVR (3.4%, p=0.2). Intensive-care stay was longer after RE-SAVR (3.4±2.9d vs. 1.9±1.8d, p&lt;0.01). Following ViV, 22.5% (n=16) of patients had mild aortic regurgitation, vs. 11.3% (n=8; p=0.25) after RE-SAVR. Mean transvalvular pressure gradients at discharge were higher post ViV (19.3±7.3 vs.12.2±5.6mmHg, p&lt;0.01). Rate of permanent pacemaker implantation was lower after ViV (9.9% vs. 27.1%, p&lt;0.01). Survival at 90- and 180-days was 93.8% and 91.8% vs. 94.4% and 94.4% after ViV and RE-SAVR respectively (p=0.87). Conclusion: Despite a higher risk profile, early mortality was not different between the two treatment arms. Although ViV resulted in elevated postoperative transvalvular pressure gradients and therefore a lower rate of device success, mortality after 180-days was similar to RE-SAVR. At present, both techniques serve as complementary approaches and allow individualized patient care.
Definition of Left Ventricular Segments for Cardiac Magnetic Resonance Imaging
Authors: Breyoni S.N. Selvadurai, Valentina O. Puntmann, David A. Bluemke, Victor A. Ferrari, Matthias G. Friedrich, Christopher M. Kramer, Raymond Y. Kwong, Massimo Lombardi, Sanjay K. Prasad, Frank E. Rademakers, Alistair A. Young, Raymond J. Kim, Eike Nagel
Journal: JACC. Cardiovascular imaging (2017)
Abstract 12959: The Relationships between Vitamin D Status and Blood Pressure in Korean Postmenopausal Women
Authors: Jin kyu Park, Jeong Hyun Kim, Jinho Shin
Journal: Circulation (2013)

Background:  Thevitamin D deficiency is worldwide concern. The vitamin D receptor is also expressed in vascular endothelial cell, which suggests that vitamin D may play a role in hypertension. The aim of this study was to investigate the association between vitamin D deficiency and blood pressure in postmenopausal women.   Methods:  We analyzed 1249 postmenopausal women 50-79 of age using National Health and Nutrition Examination Survey (KNHANES) 2011 database, which is a large and representative population-based survey.   Results:  Using a serum 25 (OH) D level of 15ng/ml as a cutoff, 35.3% of subjects were found to be vitamin D deficient. Body mass index was larger in subject with vitamin D deficiency (24.6 kg/m 2 , 95% CI 24.3-25.0 versus 24.1 kg/m 2 , 95% CI 23.9-24.4, p=0.013). After adjusting for age, body mass index, waist circumference, smoking, physical activity, subjects with vitamin D deficiency had higher systolic blood pressure (119.3 mmHg, 95% CI 113.9-124.8 versus 115.8 mmHg, 95% CI 111.2-120.3, p=0.016). However, there was no significant association between vitamin D deficiency and diastolic blood pressure (74.6 mmHg, 95% CI 71.6-77.5 versus 73.9 mmHg, 95% CI 71.0-76.9, p=0.365).   Conclusion:  In postmenopausal women, vitamin D deficiency was significantly associated with increase of systolic blood pressure. Prospective studies and randomized clinical trials are warranted to determine the role of 25(OH) D in the development of hypertension.
Effect of alcohol-based hand rub on hand microbiome and hand skin health in hospitalized adult stem cell transplant patients: A pilot study
Authors: Pranab K. Mukherjee, Jyotsna Chandra, Mauricio Retuerto, Karen A. Arters, Mary C. Consolo, A'ja Patterson, Saralee Bajaksouzian, James W. Arbogast, Todd J. Cartner, Michael R. Jacobs, Mahmoud A. Ghannoum, Robert A. Salata
Journal: Journal of the American Academy of Dermatology (2017)
Impaired Langerhans cell migration in psoriasis is due to an altered keratinocyte phenotype induced by interleukin-17
Authors: L.H. Eaton, K.T. Mellody, S.M. Pilkington, R.J. Dearman, I. Kimber, C.E.M. Griffiths
Journal: British Journal of Dermatology (2017)

Psoriasis is a common skin condition driven by increased expression of interleukin (IL)-17. Langerhans cells (LCs) are epidermal dendritic cells that regulate cutaneous immune responses. Within the uninvolved skin of patients with psoriasis, LCs display impaired migration from the epidermis.To investigate the role of keratinocytes (KCs) in the regulation of LC function and the response of KCs to IL-17.KCs were cultured from the uninvolved skin of patients with psoriasis and healthy individuals with or without IL-17 treatment and the conditioned medium examined for its ability to alter LC function in an ex vivo human skin explant model. Furthermore, we examined the effect of IL-17 on LC mobilization in psoriasis by neutralizing IL-17 in the same skin explant model.Conditioned medium from psoriasis KCs inhibited LC migration in healthy skin. Moreover, conditioned medium from healthy KCs treated with IL-17 also inhibited healthy LC migration. Finally, neutralizing IL-17 in psoriasis skin resulted in enhanced LC migration.Collectively, these data suggest that an altered KC secretome, driven by increased expression of IL-17, is responsible for impaired LC migration in the uninvolved skin of patients with psoriasis.
A Phase I/II Study of Pomalidomide and Dexamethasone with Growth Factor Support in Patients with Relapsed/Refractory Multiple Myeloma
Authors: Elisabet E. Manasanch, Hans C. Lee, Krina K. Patel, Donna M. Weber, Hun Ju Lee, Sheeba K. Thomas, Wendy Chen, Onyeka Oriabure, Maria Badillo, Vivian Graham, Feng Lei, Magda S McCarthy, Robert Z. Orlowski, Michael Wang
Journal: Blood (2017)
R-loops cause genomic instability in T helper lymphocytes from patients with Wiskott-Aldrich syndrome
Authors: Koustav Sarkar, Seong-Su Han, Kuo-Kuang Wen, Hans D. Ochs, Loïc Dupré, Michael M. Seidman, Yatin M. Vyas
Journal: Journal of Allergy and Clinical Immunology (2017)
Bipolar androgen therapy in men with metastatic castration-resistant prostate cancer after progression on enzalutamide: an open-label, phase 2, multicohort study
Authors: Benjamin A Teply, Hao Wang, Brandon Luber, Rana Sullivan, Irina Rifkind, Ashley Bruns, Avery Spitz, Morgan DeCarli, Victoria Sinibaldi, Caroline F Pratz, Changxue Lu, John L Silberstein, Jun Luo, Michael T Schweizer, Charles G Drake, Michael A Carducci, Channing J Paller, Emmanuel S Antonarakis, Mario A Eisenberger, Samuel R Denmeade
Journal: The Lancet Oncology (2017)
In vivo single cell analysis reveals Gata2 dynamics in cells transitioning to hematopoietic fate
Authors: Christina Eich, Jochen Arlt, Chris S. Vink, Parham Solaimani Kartalaei, Polynikis Kaimakis, Samanta A. Mariani, Reinier van der Linden, Wiggert A. van Cappellen, Elaine Dzierzak
Journal: The Journal of Experimental Medicine (2017)

Cell fate is established through coordinated gene expression programs in individual cells. Regulatory networks that include the Gata2 transcription factor play central roles in hematopoietic fate establishment. Although Gata2 is essential to the embryonic development and function of hematopoietic stem cells that form the adult hierarchy, little is known about the in vivo expression dynamics of Gata2 in single cells. Here, we examine Gata2 expression in single aortic cells as they establish hematopoietic fate in Gata2Venus mouse embryos. Time-lapse imaging reveals rapid pulsatile level changes in Gata2 reporter expression in cells undergoing endothelial-to-hematopoietic transition. Moreover, Gata2 reporter pulsatile expression is dramatically altered in Gata2+/− aortic cells, which undergo fewer transitions and are reduced in hematopoietic potential. Our novel finding of dynamic pulsatile expression of Gata2 suggests a highly unstable genetic state in single cells concomitant with their transition to hematopoietic fate. This reinforces the notion that threshold levels of Gata2 influence fate establishment and has implications for transcription factor–related hematologic dysfunctions.
Abstract B16: Two kills with one shot: A biomarker with therapeutic implications in poor prognosis gastric cancers
Authors: Ko Sato
Journal: Cancer Research (2017)

Abstract Bioinformatic approaches are useful to predict significance of gene expression in clinical outcome. Utilizing these non-biased approaches, we now identify that upregulation of aldosterone-regulated sodium reabsorption (ARSR) is seen in a subset of gastric cancers with poor prognosis. Our analysis of a clinical cohort of gastric cancers shows a subunit component of ARSR, SCNNIG, is indeed often overexpressed and is linked to poor survival. To understand this mechanism of the poor survival, overexpression of SCNNIG causes rapid growth of tumors in a xenograft model. Inhibition of aldosterone by spironolactone, a traditional diuretic, specifically kills cancer cells with overexpression of SCNNIG in vitro and in vivo, suggesting a clinical and therapeutic benefit for evaluating patients for this biomarker. Citation Format: Ko Sato. Two kills with one shot: A biomarker with therapeutic implications in poor prognosis gastric cancers [abstract]. In: Proceedings of the AACR International Conference: New Frontiers in Cancer Research; 2017 Jan 18-22; Cape Town, South Africa. Philadelphia (PA): AACR; Cancer Res 2017;77(22 Suppl):Abstract nr B16.
Abstract 14793: Obesity-induced Inflammation of the Visceral Adipose Tissue is Mediated by Upregulation of Arginase 1 in Vascular Endothelial Cells
Authors: Lin Yao, Anil Bhatta, Zhimin Xu, Rudolf Lucas, Yuqing Huo, Zsolt Bagi, Ruth B Caldwell, Robert W Caldwell
Journal: Circulation (2016)

Obesity-induced cardiovascular dysfunction involves pathological expansion of visceral adipose tissue (VAT). Our previous studies have shown that arginase 1 (A1) expression in vascular endothelial ...
Haploinsufficiency for the Six2 gene increases nephron progenitor proliferation promoting branching and nephron number
Authors: Alexander N. Combes, Sean Wilson, Belinda Phipson, Brandon B. Binnie, Adler Ju, Kynan T. Lawlor, Cristina Cebrian, Sarah L. Walton, Ian M. Smyth, Karen M. Moritz, Raphael Kopan, Alicia Oshlack, Melissa H. Little
Journal: Kidney International (2017)
Weekend and Out of Hours Surgical Handover (WOOSH): A Checklist Format Improves Efficiency and Patient Safety
Authors: S. Shaikh, J. Forsyth, J. Haslam, G. Hicks, A. Krishnan, K. Ren, A. Mitwalli, D. Li, K. Abbas, T. Majeed, T. Masudi, M. Peter, D. Bandyopadhyay
Journal: International Journal of Surgery (2017)
Preliminary aggregate safety and immunogenicity results from three trials of a purified inactivated Zika virus vaccine candidate: phase 1, randomised, double-blind, placebo-controlled clinical trials
Authors: Kayvon Modjarrad, Leyi Lin, Sarah L George, Kathryn E Stephenson, Kenneth H Eckels, Rafael A De La Barrera, Richard G Jarman, Erica Sondergaard, Janice Tennant, Jessica L Ansel, Kristin Mills, Michael Koren, Merlin L Robb, Jill Barrett, Jason Thompson, Alison E Kosel, Peter Dawson, Andrew Hale, C Sabrina Tan, Stephen R Walsh, Keith E Meyer, James Brien, Trevor A Crowell, Azra Blazevic, Karla Mosby, Rafael A Larocca, Peter Abbink, Michael Boyd, Christine A Bricault, Michael S Seaman, Anne Basil, Melissa Walsh, Veronica Tonwe, Daniel F Hoft, Stephen J Thomas, Dan H Barouch, Nelson L Michael
Journal: The Lancet (2017)